drugset / Trial / NCT02365532
Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the effect of oral GS-6615 on QTc interval in healthy adults with dofetilide-induced QTc prolongation.
Timeline
- Start
- 2015-02
- Primary completion
- 2015-05
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eleclazine | Small molecule | — | Oral |
| Background | Dofetilide | Small molecule | 500 ug | Oral |